Cargando…

Tamoxifen Ameliorates Peritoneal Membrane Damage by Blocking Mesothelial to Mesenchymal Transition in Peritoneal Dialysis

Mesothelial-to-mesenchymal transition (MMT) is an auto-regulated physiological process of tissue repair that in uncontrolled conditions such as peritoneal dialysis (PD) can lead to peritoneal fibrosis. The maximum expression of peritoneal fibrosis induced by PD fluids and other peritoneal processes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Loureiro, Jesús, Sandoval, Pilar, del Peso, Gloria, Gónzalez-Mateo, Guadalupe, Fernández-Millara, Vanessa, Santamaria, Beatríz, Bajo, Maria Auxiliadora, Sánchez-Tomero, José Antonio, Guerra-Azcona, Gonzalo, Selgas, Rafael, López-Cabrera, Manuel, Aguilera, Abelardo I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3634067/ https://www.ncbi.nlm.nih.gov/pubmed/23637793 http://dx.doi.org/10.1371/journal.pone.0061165

Ejemplares similares

Genomic reprograming analysis of the Mesothelial to Mesenchymal Transition identifies biomarkers in peritoneal dialysis patients
por: Ruiz-Carpio, Vicente, et al.
Publicado: (2017)

Are the Mesothelial-to-Mesenchymal Transition, Sclerotic Peritonitis Syndromes, and Encapsulating Peritoneal Sclerosis Part of the Same Process?
por: Loureiro, Jesús, et al.
Publicado: (2013)

Functional Relevance of the Switch of VEGF Receptors/Co-Receptors during Peritoneal Dialysis-Induced Mesothelial to Mesenchymal Transition
por: Pérez-Lozano, María Luisa, et al.
Publicado: (2013)

Nebivolol, a β1-adrenergic blocker, protects from peritoneal membrane damage induced during peritoneal dialysis
por: Liappas, Georgios, et al.
Publicado: (2016)

Correction: Nebivolol, a β(1)-adrenergic blocker, protects from peritoneal membrane damage induced during peritoneal dialysis
por: Liappas, Georgios, et al.
Publicado: (2017)

T Helper 17/Regulatory T Cell Balance and Experimental Models of Peritoneal Dialysis-Induced Damage
por: Liappas, Georgios, et al.
Publicado: (2015)

Corrigendum to “T Helper 17/Regulatory T Cell Balance and Experimental Models of Peritoneal Dialysis-Induced Damage”
por: Liappas, Georgios, et al.
Publicado: (2017)

Sustained low peritoneal effluent CCL18 levels are associated with preservation of peritoneal membrane function in peritoneal dialysis
por: Ossorio, Marta, et al.
Publicado: (2017)

Rapamycin Protects from Type-I Peritoneal Membrane Failure Inhibiting the Angiogenesis, Lymphangiogenesis, and Endo-MT
por: González-Mateo, Guadalupe Tirma, et al.
Publicado: (2015)

Paricalcitol Reduces Peritoneal Fibrosis in Mice through the Activation of Regulatory T Cells and Reduction in IL-17 Production
por: González-Mateo, Guadalupe T., et al.
Publicado: (2014)

Increased miR-7641 Levels in Peritoneal Hyalinizing Vasculopathy in Long-Term Peritoneal Dialysis Patients
por: Díaz, Raquel, et al.
Publicado: (2020)

Mechanisms of Epithelial-Mesenchymal Transition of Peritoneal Mesothelial Cells During Peritoneal Dialysis
por: Lee, Hi Bahl, et al.
Publicado: (2007)

Fibroblast Growth Factor 21 (FGF-21) in Peritoneal Dialysis Patients: Natural History and Metabolic Implications
por: González, Elena, et al.
Publicado: (2016)

Loosening of the mesothelial barrier as an early therapeutic target to preserve peritoneal function in peritoneal dialysis
por: Kang, Duk-Hee
Publicado: (2020)

Abnormalities in Glucose Metabolism, Appetite-Related Peptide Release, and Pro-inflammatory Cytokines Play a Central Role in Appetite Disorders in Peritoneal Dialysis
por: Avila-Carrasco, Lorena, et al.
Publicado: (2019)

Actinomyces peritonitis: removal of the peritoneal catheter unnecessary for resolution
por: Díaz, R., et al.
Publicado: (2010)

The Mesothelial Origin of Carcinoma Associated-Fibroblasts in Peritoneal Metastasis
por: Rynne-Vidal, Angela, et al.
Publicado: (2015)

Mechanisms of Peritoneal Mesothelial Cells in Peritoneal Adhesion
por: Wang, Ruipeng, et al.
Publicado: (2022)

Mesenchymal Conversion of Mesothelial Cells Is a Key Event in the Pathophysiology of the Peritoneum during Peritoneal Dialysis
por: López-Cabrera, Manuel
Publicado: (2014)

Adrenomedullin in peritoneal effluent expressed by peritoneal mesothelial cells
por: Kono, Rika, et al.
Publicado: (2013)

Role of Peritoneal Mesothelial Cells in the Progression of Peritoneal Metastases
por: Li, Junliang, et al.
Publicado: (2022)

Mesothelial-to-Mesenchymal Transition and Exosomes in Peritoneal Metastasis of Ovarian Cancer
por: Pascual-Antón, Lucía, et al.
Publicado: (2021)

Activation of salt-inducible kinase 2 promotes the viability of peritoneal mesothelial cells exposed to stress of peritoneal dialysis
por: Wang, H-H, et al.
Publicado: (2016)

Analysis of early mesothelial cell responses to Staphylococcus epidermidis isolated from patients with peritoneal dialysis-associated peritonitis
por: McGuire, Amanda L., et al.
Publicado: (2017)

An Increase of Plasma Advanced Oxidation Protein Products Levels Is Associated with Cardiovascular Risk in Incident Peritoneal Dialysis Patients: A Pilot Study
por: Gonzalez, Elena, et al.
Publicado: (2015)

Dissolved molecular hydrogen (H(2)) in Peritoneal Dialysis (PD) solutions preserves mesothelial cells and peritoneal membrane integrity
por: Nakayama, Masaaki, et al.
Publicado: (2017)

Prominent Levels of the Profibrotic Chemokine CCL18 during Peritonitis: In Vitro Downregulation by Vitamin D Receptor Agonists
por: Ossorio, Marta, et al.
Publicado: (2018)

Natural Plants Compounds as Modulators of Epithelial-to-Mesenchymal Transition
por: Avila-Carrasco, Lorena, et al.
Publicado: (2019)

Transcriptome analysis of signaling pathways of human peritoneal mesothelial cells in response to different osmotic agents in a peritoneal dialysis solution
por: Liu, Bin, et al.
Publicado: (2019)

Elabela Attenuates the TGF-β1-Induced Epithelial-Mesenchymal Transition of Peritoneal Mesothelial Cells in Patients Receiving Peritoneal Dialysis
por: Xie, Shunyun, et al.
Publicado: (2022)

Influence of dialysate temperature on creatinine peritoneal clearance in peritoneal dialysis patients: a randomized trial
por: Fontana, Francesco, et al.
Publicado: (2020)

Shorter daily dwelling time in peritoneal dialysis attenuates the epithelial-to-mesenchymal transition of mesothelial cells
por: Lee, Yi-Che, et al.
Publicado: (2014)

Retinoic Acid Improves Morphology of Cultured Peritoneal Mesothelial Cells from Patients Undergoing Dialysis
por: Retana, Carmen, et al.
Publicado: (2013)

Involvement of Mitochondrial Dysfunction in the Inflammatory Response in Human Mesothelial Cells from Peritoneal Dialysis Effluent
por: Ramil-Gómez, Olalla, et al.
Publicado: (2022)

The impact of peritoneal dialysis-related peritonitis on mortality in peritoneal dialysis patients
por: Ye, Hongjian, et al.
Publicado: (2017)

Changes in expression of four molecular marker proteins and one microRNA in mesothelial cells of the peritoneal dialysate effluent fluid of peritoneal dialysis patients
por: ZHANG, LIN, et al.
Publicado: (2013)

Effect of astragaloside IV and the role of nuclear receptor RXRα in human peritoneal mesothelial cells in high glucose-based peritoneal dialysis fluids
por: Zhu, Weiwei, et al.
Publicado: (2019)

Pathophysiological Changes to the Peritoneal Membrane during PD-Related Peritonitis: The Role of Mesothelial Cells
por: Yung, Susan, et al.
Publicado: (2012)

Expression of XBP1s in peritoneal mesothelial cells is critical for inflammation-induced peritoneal fibrosis
por: Liu, An, et al.
Publicado: (2019)

Proteomic profile of mesothelial exosomes isolated from peritoneal dialysis effluent of children with focal segmental glomerulosclerosis
por: Bruschi, Maurizio, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8bngh3en3g3d6fpqj937l7n1u1